YungShin Global Holding (3705) is a TW-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of NT
4.4B, trading at NT$54.00 on the TAI. This SniperIQ fundamentals page covers YungShin Global Holding's valuation (P/E 18.2x, P/B 2.0x), profitability (net margin 9.9%), revenue (NT$8.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market CapNT
4.4B
P/E (TTM)18.2x
Net Margin9.9%
Revenue (FY25)NT$8.4B
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is YungShin Global Holding's market cap?
YungShin Global Holding (3705) has a market capitalization of approximately NT
4.4B, trading at NT$54.00 on the TAI. Market cap moves with the live share price.
What is YungShin Global Holding's P/E ratio?
YungShin Global Holding's trailing twelve-month P/E ratio is 18.2x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is YungShin Global Holding?
YungShin Global Holding runs a net profit margin of 9.9%, a gross margin of 43.1%, and an operating margin of 15.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does YungShin Global Holding generate?
YungShin Global Holding reported revenue of NT$8.4B for fiscal year 2025, with net income of NT$881M and earnings per share (EPS) of 3.3. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does YungShin Global Holding pay a dividend?
YungShin Global Holding offers a trailing dividend yield of about 5.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is YungShin Global Holding financially healthy?
YungShin Global Holding carries a debt-to-equity ratio of 0.16x and a current ratio of 2.63x, with a market beta of 0.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is YungShin Global Holding a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For YungShin Global Holding (3705) the key facts are: market cap NT
4.4B, P/E 18.2x, revenue NT$8.4B, 52-week range 51.9-65.6. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track YungShin Global Holding's full fundamentals live
Get YungShin Global Holding's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.